Florbetapir Calibration数据集:在GAAIN网站下载“Florbetapir Calibration”数据集,包括46名接受11C-PIB PET和18F-Florbetapir PET扫描的受试者;其中,年轻组13名(年龄≤45岁),老年组33名[临床诊断包括AD、很可能AD、轻度认知障碍(mild cognitive impairment, MCI)、≥75岁的高危人群,以及>50岁的认知正常受试者]。(2...
Florbetapir Calibration数据集:在GAAIN网站下载“Florbetapir Calibration”数据集,包括46名接受11C-PIB PET和18F-Florbetapir PET扫描的受试者;其中,年轻组13名(年龄≤45岁),老年组33名[临床诊断包括AD、很可能AD、轻度认知障碍(mild cog...
Florbetapir Calibration数据集:在GAAIN网站下载“Florbetapir Calibration”数据集,包括46名接受11C-PIB PET和18F-Florbetapir PET扫描的受试者;其中,年轻组13名(年龄≤45岁),老年组33名[临床诊断包括AD、很可能AD、轻度认知障碍(mild cognitive impairment, MCI)、≥75岁的高危人群,以及>50岁的认知正常受试者]。(2...
18F-florbetapir是一种新型的淀粉样蛋白靶向放射性示踪剂,正电子发射断层扫描/计算机断层扫描(PET/CT)可以量化系统性轻链淀粉样变中的左心室淀粉样蛋白负荷。然而,其预后价值尚不清楚。 Objectives: The authors' aim was to evaluate the ...
The PET tracer [18F]florbetapir is a specific fibrillar amyloid-beta (Aβ) biomarker. During the late scan phase (> 40 min), it provides pathological information about Aβ status. Early scan phase (0-10 min) can provide FDG-'like' information. The current investigation tested the ...
Florbetapir 18F 来自 Semantic Scholar 喜欢 0 阅读量: 1587 作者:赵文芳,董金华 摘要: Florbetapir18F(18F-AV-45)是由美国Eli Lilly and Company开发的一种放射性诊断剂,于2012年4月获美国FDA批准上市,其商品名为Amyvid.该药为注射剂,用于诊断阿尔茨海默病(Alzheimer's disease,AD)或其他认知功能减退的疾病....
摘要: Purpose We investigated dual-phase 18F-florbetapir (AV-45/Amyvid) PET imaging for the concomitant detection of brain perfusion deficits and beta-amyloid deposition in patients with Alzheimer's...关键词: Dual-phase scan Perfusion deficits Amyloid 18F-Florbetapir (AV-45/Amyvid Alzheimer’s ...
242070 Introduction: 18F-florbetapir may be useful for the diagnosis of AL amyloidosis. However, there are few relevant studies, and the ability of 18F-florbetapir to detect and quantify cardiac amyloid is still unclear. The relationship between 18F-florbetapir metabolic parameters and clinical indicato...
Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomographyIncreased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) po...
Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls. The purpose of this study was to determine how clinical interpretations of the (18)F-amyloid tracer florbetapir compares diagnostically with (18)F-FDG PET ......